PAD Treatment: Medicines, Exercise and Procedures

PAD treatment has two aims that people often conflate: keeping you alive, and keeping you walking. They involve different interventions, and the first one matters more than most patients are told. The good news is that both respond well to treatment — and for most people the most powerful parts involve no procedure at all.

Not a routine treatment question

  • A leg or foot that suddenly turns cold, pale, numb, weak or severely painful — call 911.
  • Pain in the toes or forefoot at rest, a wound that is not healing, or a new dark patch on the foot — be seen the same day. Skin that has turned black, gray or dark purple, or looks dead, needs an emergency department now. That is a threatened limb, and treatment moves from optional to urgent. Rest pain and CLTI →

The thing worth understanding first

Narrowed leg arteries are a marker of the same disease in the heart and brain. A large part of PAD treatment is therefore aimed at preventing heart attack and stroke rather than at the legs — and that part has the biggest effect on how long you live, even though it does nothing for the walking pain you came in about. The 2024 American College of Cardiology and American Heart Association guideline reflects this: a statin, an antiplatelet medicine for anyone with symptoms, and treatment of high blood pressure all carry its strongest level of recommendation.

PAD treatment chart: quitting smoking, statins and other medicines protect heart and limb; walking programs add distance
Most of the benefit comes from parts that involve no procedure at all. The table below lists every element of the plan.

The plan at a glance

Part of treatment What it is for Worth knowing
Stopping smoking Heart, brain and limb The most effective single change; smokers progress to limb-threatening disease more often
Statin Heart, brain and limb For everyone with PAD, whatever the cholesterol level
Antiplatelet medicine, sometimes with low-dose rivaroxaban Heart and brain; the combination also protects the limb The combination prevents more events but causes more bleeding
Blood pressure and diabetes treatment Heart and brain Treating blood pressure has not been shown to harm the legs
Structured walking program Walking distance Strong evidence; the benefit fades if you stop
Cilostazol Walking distance Modest gains; not for anyone with heart failure
Angioplasty, stent or bypass Walking, or saving a threatened limb Treats the blockage, not the disease
Daily foot care The limb Matters more, not less, after a procedure

Track one: reducing cardiovascular risk

  • Stopping smoking. The single most effective change available. Quitting slows the disease and lowers the risk of limb problems and death; in Cleveland Clinic’s figures, about 86 in 100 people who quit after a PAD diagnosis are alive five years later, compared with 69 in 100 who keep smoking. The guideline recommends a quit plan that pairs medicine (varenicline, bupropion or nicotine replacement) with counseling or a cessation program, rather than willpower alone. A quit plan with your care team →
  • Cholesterol treatment. A statin is recommended for everyone with PAD, whatever the starting cholesterol, usually a high-intensity one aimed at lowering LDL cholesterol by at least half. If LDL stays at 70 mg/dL or higher, adding ezetimibe or a PCSK9 inhibitor is reasonable. Statins protect the legs as well as the heart: in an analysis of more than 138,000 patients cited by the guideline, statin use was linked to about 30% fewer major limb events and 35% fewer amputations.
  • Blood pressure treatment. For people with PAD and high blood pressure, the guideline target is below 130/80 mm Hg. The old worry that lowering blood pressure starves the legs has not been borne out: studies of treated patients, including those on beta blockers, have shown improvement in claudication and function, with no sign of worse limb outcomes.
  • Diabetes management, where relevant — including newer medicines chosen partly for their cardiovascular effects. In type 2 diabetes, the guideline gives its strongest recommendation to two drug classes for their cardiovascular benefit: GLP-1 receptor agonists and SGLT2 inhibitors.

Track two: antithrombotic therapy

An antiplatelet medicine — usually aspirin or clopidogrel — is standard. For many people with symptomatic PAD, and after a procedure to restore blood flow, the guideline also supports adding a very low dose of the anticoagulant rivaroxaban to low-dose aspirin, provided bleeding risk is not high. In the VOYAGER PAD trial of 6,564 people who had just had a leg procedure, the combination lowered the three-year rate of major limb and heart events from 19.9% to 17.3%, at the cost of more bleeding. A full-dose blood thinner for PAD alone, with no other reason such as atrial fibrillation, is not recommended. Whether it suits you depends on your bleeding history and your other conditions, and it is a decision to make with the clinician who knows both.

Track three: structured exercise

For stable claudication, supervised exercise therapy carries the guideline’s strongest recommendation. In a Cochrane review of 32 trials, exercise programs added on average about 82 meters of pain-free walking and 120 meters of maximum walking distance, with benefit still seen up to two years later. Programs typically run three or more times a week for at least twelve weeks: walk to moderate claudication discomfort, rest, and repeat. Medicare covers up to 36 supervised sessions with a referral.

This is a prescribed, structured program, not general advice to be more active — and it is for people with a confirmed, stable diagnosis. Walking into pain is the wrong instruction for someone with a wound, rest pain, or an undiagnosed limb. How structured walking works →

Track four: symptom-specific medicine

Cilostazol is the medicine recommended specifically to improve claudication symptoms and walking distance. The gains are modest: in a Cochrane review of 16 trials, about 26 meters more pain-free walking and 40 meters more maximum walking than placebo, with headache a common side effect. It can start to help within two to four weeks, with the full effect by about twelve. It must not be used by anyone with heart failure of any severity. Whether to try it is a conversation about your particular situation. Pentoxifylline, an older medicine, and chelation therapy are not recommended.

Track five: revascularization

Restoring blood flow mechanically. The main options:

Procedure What it does Typically considered when
Angioplasty A balloon on a catheter widens the narrowed segment, sometimes coated with a drug to slow re-narrowing Suitable anatomy; shorter narrowings
Stent A mesh tube holds the vessel open, often after angioplasty Often when ballooning alone does not keep the artery open
Atherectomy Plaque is cut or shaved away Certain lesion types, often as an adjunct
Bypass surgery A vein or synthetic graft routes blood around the blockage Long or complex disease; when endovascular options are unsuitable or have failed

Revascularization is generally considered when symptoms meaningfully limit daily life despite medical therapy and exercise, or when the limb is threatened by rest pain or tissue loss. It is not recommended just to prevent progression when there are no symptoms, or when exercise and medicines are already working. In the threatened-limb situation it moves from optional to urgent. When a limb is threatened, the choice between a catheter procedure and bypass depends on the anatomy and on whether a good vein is available. In the BEST-CLI trial of 1,830 patients, those with a usable great saphenous vein did better with bypass, with 32% fewer major limb events or deaths and 27% fewer above-ankle amputations; for those without a usable vein, the two approaches were similar.

Importantly, a procedure treats a blockage; it does not treat the disease. Risk-factor treatment continues afterwards, and re-narrowing is a real possibility that surveillance is designed to catch. Life after a procedure →

Questions worth asking before any procedure

  1. What is the goal — walking further, saving tissue, or relieving rest pain?
  2. Have I had a proper trial of supervised exercise and medicines first?
  3. What are the chances this artery narrows again, and how would we know?
  4. What happens if I do nothing for now?
  5. Who will follow me up afterwards, and how often?

Where foot care fits

Reduced blood flow means small injuries heal slowly and get infected easily. Check your feet every day, wear seamless socks and well-fitting low-heeled shoes, never go barefoot, and leave corns, calluses and ingrown nails to a professional rather than treating them yourself. If you also have diabetes, the National Heart, Lung, and Blood Institute advises a foot examination twice a year. The American Heart Association calls foot care crucial in every form of PAD and names podiatrists as key members of the care team, and it matters more, not less, after a successful procedure. Daily foot care →

What is not treatment

No supplement, compression garment, massager, heat wrap or electrical circulation device opens a narrowed artery. Some are pleasant and a few have specific uses in other conditions. None of them is an alternative to the tracks above, and compression in particular can be unsuitable when arterial supply is poor. “Circulation boosters” examined →

From the clinic

From the foot end of things, the most important treatment decision is often made before anyone talks about stents: whether a foot with poor circulation gets operated on, trimmed aggressively or put in a tight shoe. A bunion, hammertoe or ingrown nail that would be routine in a well-supplied foot can become a non-healing wound in one that is not. If you have PAD and someone is planning foot surgery, make sure they know — and ask whether your circulation has been checked first.

Common questions

Do I need a stent?

Many people with claudication do not. For walking distance specifically, supervised exercise performs well, and medical therapy addresses the cardiovascular risk that a stent does not. Procedures come into their own when symptoms are genuinely limiting despite those, or when the limb is threatened. It is a reasonable question to ask directly: what does this procedure change for me that exercise and medicines would not?

Do I need a blood thinner?

Almost everyone with symptomatic PAD should take a single antiplatelet medicine, usually low-dose aspirin or clopidogrel. Some people are also offered very-low-dose rivaroxaban alongside aspirin, which prevents more heart and limb events but increases bleeding. A full-dose anticoagulant is not recommended for PAD alone; those are for other reasons, such as atrial fibrillation or a clot.

Will I lose my leg?

For most people with claudication, the risk is low: only about 1 to 3 in 100 progress to limb-threatening disease each year. The risk rises sharply with rest pain, non-healing wounds and gangrene (historically, up to 30% of people at that stage needed an amputation within a year), which is why those are treated as urgent and why stopping smoking and daily foot care matter so much.

Will treatment cure PAD?

The plaque is not usually reversed. What changes substantially is walking distance, symptoms, and the risk of heart attack, stroke and limb loss. Those are the outcomes treatment is aimed at, and they respond well.

How long until I notice a difference?

Revascularization can change symptoms immediately. Exercise programs typically show benefit over weeks to a few months. Cilostazol can start working within two to four weeks, with its full effect by about twelve. Risk-factor treatment produces no sensation at all — its benefit is in events that do not happen, which is unsatisfying and also the point.

Can I stop my statin if my cholesterol is now normal?

That is a question for the prescriber, and the usual answer is no. In PAD the statin is prescribed for its effect on cardiovascular events, not only for the cholesterol number, so a normal result generally reflects the medicine working rather than the need for it ending.

Are there supplements that help PAD?

None has been shown to open narrowed arteries or replace the treatments above. If you take any supplement, tell your prescriber — some interact with blood thinners and antiplatelet medicines and raise bleeding risk.

Written by Tom Biernacki, DPM, FACFAS. Published 20 September 2026. Updated 15 October 2026. General education, not medical advice. Treatment decisions belong with the clinicians who know your full history.